M Kůta
Impact in
-
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 2
- Oncology 2
- Cancer-related Molecular Pathways 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- Petr Zatloukal (3 shared papers)Jaromı́r Roubec (3 shared papers)Adrie Gunther (2 shared papers)Giuseppe Giaccone (2 shared papers)Karijn Floor (1 shared paper)Setareh Shamsili (2 shared papers)Rob J. van Klaveren (1 shared paper)Luboš Petruželka (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (1 paper)Journal of Clinical Oncology (1 paper)Lung Cancer (1 paper)Annals of Oncology (1 paper)PubMed (1 paper)
- Partner nations
- CzechiaJapanUnited States
In The Last Decade
M Kůta
4 papers receiving 389 citations
Peers
Comparison fields: 5 of 56
- Oncology 163
- Pulmonary and Respiratory Medicine 124
- Cancer Research 42
- Molecular Biology 188
- Toxicology 6
Countries citing papers authored by M Kůta
This map shows the geographic impact of M Kůta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Kůta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Kůta more than expected).
Fields of papers citing papers by M Kůta
This network shows the impact of papers produced by M Kůta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Kůta. The network helps show where M Kůta may publish in the future.
Co-authors
The 25 scholars most cited alongside M Kůta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 220 | |
| 2 | 2003 | 141 | |
| 3 | 2003 | 36 | |
| 4 | A phase II, monotherapy study of YM155, a novel survivin suppressant, in previously treated advanced stage non-small cell lung cancer (NSCLC) | 2007 | 2 |
| 5 | [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study]. | 1998 | 1 |
About M Kůta
M Kůta is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Genetics, having authored 5 papers that have together received 400 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (2 papers), Cancer-related Molecular Pathways (1 paper), Estrogen and related hormone effects (1 paper), Breast Cancer Treatment Studies (1 paper), Multiple and Secondary Primary Cancers (1 paper), Cell death mechanisms and regulation (1 paper), Cancer Treatment and Pharmacology (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (163 citations), Pulmonary and Respiratory Medicine (124 citations), Cancer Research (42 citations), Molecular Biology (188 citations) and Toxicology (6 citations). M Kůta has collaborated with scholars based in Czechia, Japan and United States. Frequent co-authors include Petr Zatloukal, Jaromı́r Roubec, Adrie Gunther, Giuseppe Giaccone, Karijn Floor, Setareh Shamsili, Rob J. van Klaveren, Luboš Petruželka, Vı́tězslav Kolek and Tomáš Skácel. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Clinical Oncology, Lung Cancer, Annals of Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.